Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation Oral praziquantel anthelmintic effect by cyclodextrin complexation Marcelo Bispo de Jesus et al.

Journal of Drug Targeting

Volumn 18, Issue 1, 2010, Pages 21-26

  De Jesus, Marcelo Bispo ^a   Pinto, Luciana De Matos Alves ^b   Fraceto, Leonardo Fernandes ^a,c   Magalhães, Luiz Augusto ^a   Zanotti Magalhães, Eliana Maria ^a   De Paula, Eneida ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cyclodextrin; Inclusion complex; Praziquantel; Schistosomiasis

Indexed keywords

ALBENDAZOLE; BETA CYCLODEXTRIN; MEBENDAZOLE; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; FEMALE; MICE; MICROSCOPY, ELECTRON, SCANNING; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SOLUBILITY;

EID: 72749126555     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903131677     Document Type: Article

References (30)

1. Andersson KL, Chung RT. (2007). Hepatic schistosomiasis. Curr Treat Options Gastroenterol, 10, 504-512.
2. Becker K, Hu Y, Biller-Andorno, N. (2006). Infectious diseases-a global challenge. Int J Med Microbiol, 296, 179-185.
3. Becket G, Schep LJ, Tan MY. (1999). Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins. Int J Pharm, 179, 65-71.
4. Bernad-Bernad MJ, Gracia-Mora J, Diaz D, Castillo-Blum SE. (2008). Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction media. Curr Drug Discov Technol, 5, 146-153.
5. Bethony JM, Diemert DJ, Oliveira SC, Loukas A. (2008). Can schistosomiasis really be consigned to history without a vaccine? Vaccine, 26, 3373-3376.
6. Cabeça LF, de Paula E, Marsaioli AJ. (2008). Topology of a ternary complex (proparacaine-cyclodextrin-liposome) by 1H-NMR (STD). Magn Reson Chem, 46, 832-837.
7. Castillo JA, Palomo-Canales J, Garcia JJ, Lastres, JL, Bolas F, Torrado JJ. (1999). Preparation and characterization of albendazole betacyclodextrin complexes. Drug Dev Ind Pharm, 25, 1241-1248.
8. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, Tchuente LA, Pica-Mattoccia L, Troiani AR, El-Din SH, Sabra AN, Albin J, Engels D, Doenhoff MJ. (2004). Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int J Parasitol, 34, 979-987.
9. Cioli, D, Pica-Mattoccia L. (2003). Praziquantel. Parasitol Res, 90(Supp. 1), S3-S9.
10. de Jesus MB, Pinto LMA, Fraceto LF, Takahata Y, Lino AC, Jaime C, de Paula E. (2006). Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance. J Pharm Biomed Anal, 41, 1428-1432.
11. el-Arini SK, Leuenberger H. (1998). Dissolution properties of praziquantel- PVP systems. Pharm Acta Helv, 73, 89-94.
12. Fernandes SA, Cabeça LF, Marsaioli AJ, de Paula E. (2007). Investigation of tetracaine complexation with beta-cyclodextrins and p-sulphonic acid calix[6]arenes by nOe and PGSE NMR. J Incl Phenom Macrocycl Chem, 57, 395-401.
13. Giordano F, Novak C, Moyano JR. (2001). Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim Acta, 380, 123-151.
14. Gonzalez-Esquivel D, Rivera J, Castro N, Yepez-Mulia L, Jung Cook H. (2005). In vitro characterization of some biopharmaceutical properties of praziquantel. Int J Pharm, 295, 93-99.
15. Hagan P, Appleton CC, Coles GC, Kusel JR, Tchuem-Tchuente LA. (2004). Schistosomiasis control: Keep taking the tablets. Trends Parasitol, 20, 92-97.
16. Hill J. (1956). Chemotherapeutic studies with laboratory infections of Schistosoma mansoni. Ann Trop Med Parasitol, 50, 39-48.
17. Hrcková G, Velebny S. (1997). Effect of praziquantel and liposomeincorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology, 114(Pt 5), 475-482.
18. Johnson Jr, CS. (1999). Diffusion ordered nuclear magnetic resonance spectroscopy: Principles and applications. Prog Nucl Magn Reson Spectrosc, 34, 203-256.
19. King CH, Dangerfield-Cha M. (2008). The unacknowledged impact of chronic schistosomiasis. Chronic Illn, 4, 65-79.
20. Matsui Y, Tokunaga S. (1996). Internal reference compounds available for the determination of binding constants for cyclodextrin complexes by 1H NMR spectrometry. Bull Chem Soc Jpn, 69, 2477-2480.
21. Mourão SC, Costa PI, Salgado HR, Gremiao MP. (2005). Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes. Int J Pharm, 295, 157-162.
22. Sathigari S, Chadha G, Lee YH, Wright N, Parsons DL, Rangari VK, Fasina O, Babu RJ. (2009). Physicochemical Characterization of Efavirenz-Cyclodextrin Inclusion Complexes. AAPS Pharm Sci Tech, 10(1), 81-87.
23. Shehatta I. (2002). Cyclodextrins as enhancers of the aqueous solubility of the anthelmintic drug mebendazole: Thermodynamic considerations. Monatsh Chem, 133, 1239-1247.
24. Sinha VR, Anitha R, Ghosh S, Nanda A, Kumria R. (2005). Complexation of celecoxib with beta-cyclodextrin: Characterization of the interaction in solution and in solid state. J Pharm Sci, 94, 676-687.
25. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. (2006). Schistosomiasis and water resources development: Systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis, 6, 411-425.
26. Waldeck AR, Kuchel, PW, Lennon AJ, Chapman BE. (1997). NMR diffusion measurements to characterise membrane transport and solute binding. Prog Nucl Magn Reson Spectrosc, 30, 39-68.
27. Wimmer R, Aachmann FL, Larsen KL, Petersen SB. (2002). NMR diffusion as a novel tool for measuring the association constant between cyclodextrin and guest molecules. Carbohydr Res, 337, 841-849.
28. Xiao SH, Catto BA, Webster LT, Jr. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis, 151, 1130-1137.
29. Yolles TK, Moore DV, De Guisti DL, Ripsom C, Meleney HE. (1947). A technique for the perfusion of laboratory animals for the recovery of schistosomes. J Parasitol, 33, 419-426.
30. Zhang CW, Xiao SH, Utzinger J, Chollet J, Keiser J, Tanner M. (2009). Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefoquine. Parasitol Res (in press).